Please support European Obesity Day

European Obesity Day (EOD) takes place this coming Saturday, 21 May, and is aimed at raising awareness and increasing knowledge about obesity and the many other diseases on which it impacts.

EOD is a major annual initiative for the European Association for the Study of Obesity (EASO) and so would like to ask you to support the activities by joining in the conversation on social media. It will help us to reach more of the policymakers, politicians, healthcare professionals, patients and the media who we are targeting with important messages about the need to take obesity more seriously.

There are several ways you can show your support:

In line with the Action for a Healthier Future theme for EOD 2016, we hope we can count on your support.

EASO urges action in advance of European Obesity Day 2016


Saturday 21 May 2016 is European Obesity Day. As the leading organisation representing obesity research and clinical practise obesity in Europe, EASO today warns that unless something is quickly done to tackle the region’s rising obesity epidemic, Europe faces devastating impact on healthcare costs and productivity.

EASO, our 32 national European membership organisations and Patient Council urge wide stakeholder engagement to tackle the crisis.

EASO Speaker Spotlight Interview- Grace O’Malley

Dr. Grace O’Malley chairs the ASOI and works as a research-clinician in the area of childhood obesity. She is a member of the EASO Childhood Obesity Task Force and the European Childhood Obesity Group. Dr. O’Malley is a founding member of ASOI and serves on the Editorial Boards of a number of obesity-related publications. Her research focuses on the pathogenesis and therapy of childhood obesity and related co-morbidities, along with the use of novel treatments (ICT based and mobile health) for the prevention and treatment of obesity. In her role as Clinical Specialist Physiotherapist, she highlights the role of physical fitness for the prevention and treatment of obesity in children.

Dr. O’Malley, please tell us a bit about yourself: where are you from, where did you grow up? Where do you live now?

I am from the ‘Fair City’ Dublin Ireland. I have lived here for most of my live save for some training and research experience in South Africa and North America.

Our readers would enjoy learning about your favourite activities, hobbies, and interests outside of your professional work:

Outside of work I love to cycle, walk by the sea, grow vegetables and flowers in my allotment or cook. I also love music so try my best to spend as much time as possible playing guitar and singing. When time allows, I enjoy exploring new places and I’m very grateful that I have been able to travel quite a bit…long summer holidays during college were great for this!

We would like to learn more about your clinical work with children and teens with obesity.

As a physiotherapist I am keenly interested in understanding barriers which may or may not exist. Being aware of such barriers is vital in order to maximise the potential, wellbeing and independence of those I work with. The physiotherapy discipline involves assessment and treatment planning, encompassing multiple body systems including the respiratory; cardiovascular; musculoskeletal; neurological and genitourinary systems. Around 10 years ago, children with obesity started presenting more often to our physiotherapy department with joint pain, balance problems, breathing difficulties and continence issues. These children were diagnosed with simple obesity. However there was very little offered in our hospital in terms of evidence-based treatment. From that time, I worked with a team of progressive clinicians to develop an obesity service.

My main clinical focus is on assessing the strengths and difficulties the child/teen has from a physical perspective, and includes testing of the musculoskeletal and cardiorespiratory systems to measure motor skill, balance, strength, gait and aerobic capacity. Regardless of the shape, size or ability of a child, these parameters of physical fitness influence how the child will play and participate with their peers. The prospect of future diabetes, stroke or heart disease may be in the distant future for many children, however the issues of social isolation, bullying and not being able to play with peers are far more important during childhood itself. Thus focusing an assessment on their concerns is key to building a good relationship and is very often crucial to subsequent treatment success. Children and their parents are often more concerned about falling, being excluded from games in school and not being able to wear clothes they like than they are about their metabolic health!

Treatment involves developing a tailored plan for each family based on current knowledge from the areas of exercise therapy and training, motivational interviewing and goal setting. In our centre we offer both one-to-one care and group-based treatment – we are lucky to have nursing, paediatrics, dietetics, psychology and physiotherapy working together.

Working with children who are clinically obese poses unique challenges in that there are often multiple physical and psychological co-morbidities present, obesity may be a symptom of more complex psychosocial difficulties within the family, or often we are trying to encourage families to change aspects of their lives in an environment that is unforgivingly obesogenic. The work is, not only incredibly rewarding (as offering care at an opportune time really can change the lives of the families we see), but also provides tremendous opportunity to learn much about how the human body responds to a changing environment.

Please tell us about your research project using tech to improve management of clinical obesity.

I was lucky to spend some time at the Yale Obesity Clinic working with Prof. Sonia Caprio and Mary Savoye. Throughout my time working with the Bright Bodies intervention and in clinic, I became acutely aware of a serious supply/demand obstacle. Even in a service that was producing substantial effects and world-class research, there was a limit in the numbers that could be treated. When I returned to Ireland I became interested in the potential for mobile-health tools to bridge this gap in access to treatment. Unlike the programme available at Yale, childhood obesity services in Ireland were wholly under-developed and best-practice treatment was only available in Temple Street Children’s University Hospital. Many families in our service commented on the often negative experiences they had when engaging with the healthcare system. Parents often expressed how the healthcare professionals they met blamed them for their child’s obesity and made them feel like they were ‘bad’ parents. As such, I felt it was really important to develop some sort of mHealth system that was evidence based and could be used in conjunction with available treatments. Even if an online treatment was not as clinically effective as best-practice in-person care, there was a chance that it might be better than looking for help from healthcare professionals with little experience and negative attitudes which could potentially have an iatrogenic effect. I was successful in my application for a PhD fellowship with the Health Research Board of Ireland and began working on a PhD in Medicine (Epidemiology and Public Health) which sought to explore how technology-based tools could be integrated into the clinical care of obesity. I developed my PhD under the wonderful mentorship of Prof. Ivan Perry at University College Cork and we succesfully applied for additional funding from the Children’s Fund for Health at Temple Street and the National Children’s Research Centre, We first spoke to our patients to learn what type of technology they would find acceptable and began development on an Android application and remote system that could be used in treatment. We then designed a usability study and a clinical trial that could test the effectiveness of using the system. The front-end application uses best-practice evidence for behavioural change in an attempt to facilitate health promotion and weight management in teenagers with obesity. The trial is ongoing and our next step is to figure out how to sustain the service, as our research funding is coming to an end.

Very interesting Grace, and a real opportunity to support an important intervention for the right funder. How did your original interest in the field develop, and how did you come to focus on paediatric obesity?

My original interest came from seeing children present for musculoskeletal injury and fractures. I began to consider how physical barriers early in life could impact participation in health-enhancing physical activity. As I read more and listened to the life stories of patients and their parents, my first-hand understanding of the social determinants of health increased and I began to consider and integrate a perspective of the bigger picture – that is, how the food, physical activity, agricultural, media and economic environments effect these little developing human bodies.

Can you share some of the particular challenges of your work? And perhaps some of the joys?

The challenges are many as there are few areas of health and medicine that provide so many barriers. Firstly stigma and discrimination are rampant within schools, healthcare systems and the media. One of my patients with a very complex situation overcame his physical and psychological barriers. He had sustained a very complicated fracture/dislocation of a lower limb, and had developed a lot of anxiety and fear of people, but through treatment he managed to get moving and go outside again. He was doing well until a complete stranger stopped his car one day and screamed abuse at him on the street – why – because of his shape. He was devastated of course, and it knocked him back again.

Funding is a big issue as everyone working in this area knows (particularly those developing non-pharmalogical interventions). In addition, many of our families have difficult social circumstances and the emotional impact can be a challenge. At a macro-level, our current economic model is a challenge where profit seems to dictate how we organise our communities, our social supports and structures. The unbridled marketing of unhealthy edible products as ‘food’ is unacceptable to me and at a local level our Irish society (ASOI) has been supporting initiatives to limit childhood exposure to this. These challenges are felt throughout Europe by those working in this field and thankfully through EASO and the European Childhood Obesity Group I have personally had an immense amount of support and encouragement to keep going. The professional network is so important and through it I’m delighted to have made good friends too.

Thankfully, the joys balance out the challenges of working in this area…hearing a young child tell you that they can play at school and have made a new friend since starting treatment is heart-warming. Often patients attend having received a recommendation from someone at school or work and this encourages our team to feel like we are doing something right. When we play games and exercise with the children in our group programme ( we watch with pride as the children become more fit and more confident, encourage one another, and develop friendships. We all laugh a lot during the sessions and they are positive times for us all. Some of our patients have engaged with the media to highlight the condition of obesity and the importance of treatment. We are very proud to see these young people represent themselves in the media and speak articulately about how obesity has affected their young lives. Ultimately, seeing how our support can empower families and facilitate fundamental change is really rewarding. We intend that each of our patients develops and reaches not only their ‘health potential’ but also their potential in school, in their social interactions and within their families.

The COTF has recently published a position statement declaring that childhood obesity is a chronic disease in children and adolescents, requiring specialised treatment. Do you foresee any changes as a result of this declaration?

I think without careful engagement with the media this statement will polarise the public, particularly online. There is so much to do with regard to increasing the public’s understanding regarding ‘why’ COTF consider clinical obesity as a chronic disease in childhood. Hopefully this statement will facilitate access to treatment for patients and will encourage the very best planning and honorable actions from our scientists, healthcare professionals, educators, policy makers, industry partners and public representatives – as we find ways to address the biopsychosocial drivers of obesity, in an effort that needs to be similar strategically to addressing climate change.

2016 EASO Congress: Late Breaking Abstracts

In 2016 the congresses of EASO (ECO2016) and the IFSO European Chapter (2016 IFSO-EC Annual Congress) will merge to create the 2016 European Obesity Summit (EOS2016). This exciting congress will take place in Gothenburg, Sweden from 1 to 4 June 2016.

You still have a chance to contribute to the EOS2016 scientific programme. We will accept Late Breaking (Hot Topic) abstracts until 31st March 2016. Abstract submission is free, so please visit the congress website to submit.

EASO Task Force Teaching Courses will take place on Wednesday 1st June. Please plan your journey so that you can participate.

If you want to make significant savings, remember to register before the early bird deadline of 31st March 2016. Visit the congress website for online registration.

We look forward to welcoming you to Gothenburg!

EASO Congress Speaker Spotlight: Dr. Philip Schauer

Philip R. Schauer, MD, is Chief of Minimally Invasive General Surgery and Director of the Cleveland Clinic Bariatric and Metabolic Institute. He is also Professor of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is immediate Past President of the American Society for Metabolic and Bariatric Surgery.

After receiving his medical degree from the Baylor College of Medicine in Houston, Dr. Schauer completed his residency in surgery at the University of Texas, where he served as Chief Resident of General Surgery. He then completed a fellowship in laparoscopic surgery at Duke University Medical Centre in Durham, N.C. Prior to joining Cleveland Clinic in 2004, Dr. Schauer served as Director of Endoscopic Surgery, Director of Bariatric Surgery and Director of the Mark Ravitch/Leon Hirsch Centre for Minimally Invasive Surgery at the University of Pittsburgh Medical Centre.

Dr. Schauer’s clinical interests include surgery for severe obesity, minimally invasive surgery (laparoscopic) and gastrointestinal surgery. He has performed more than 4,000 operations for severe obesity. His research interests include the pathophysiology of obesity and related diseases, physiologic effects of laparoscopic surgery on postoperative injury and recovery, and outcomes of laparoscopic management of obesity, gastrointestinal diseases and hernias. He has also participated in the development of new minimally invasive, endoscopic and laparoscopic operations.

New concepts in surgical training and education have been a major focus of his educational interests. He has authored more than 200 scientific papers, editorials, textbook chapters, abstracts and video productions. He has been an invited speaker for more than 100 regional, national and international lectures on the subject of obesity surgery and laparoscopic surgery. He has been on the board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) for the last 5 years.

You have been named one of the Best Doctors in America for 5 consecutive years. That’s really impressive!  Please tell us a bit about yourself; where are you from, where did you grow up? Where do you live now and how long have you been with the Cleveland Clinic?

I was born in Phoenix, Arizona but spent my childhood in Fairfax, Virginia until my second year of high school. In the late 1970s, my family moved to Dallas, Texas, where I finished high school. I completed my undergraduate education at Texas A&M University and then went to the Baylor College of Medicine in Houston, Texas. I did my surgical residency training at the University of Texas at San Antonio and later my fellowship in advanced laparoscopic surgery at Duke University,  in Durham, North Carolina. In 1995, I started my career at the University of Pittsburgh and stayed there for 10 years prior to joining Cleveland Clinic.

You have held several high profile clinical  posts, focusing on surgery for severe obesity and minimally invasive surgery. How did your original interest in obesity surgery develop?

After completing my fellowship in advanced laparoscopic surgical training at Duke, I became interested in the use of minimally invasive surgery (MIS) for bariatric patients. I realised the benefits of MIS to those patients – a less invasive operation with reduced morbidity and mortality. At that time, I also noticed how surgical weight-loss operations improve the quality of life of patients suffering from obesity and associated core morbidities, like diabetes.

After discovering that gastric bypass surgery quickly and dramatically improves diabetes, I became interested in developing a randomised clinical trial, now known as STAMPEDE, to directly compare surgery to medical treatment. The study has elucidated many important aspects of metabolic surgery, which has led to a much greater understanding of the pathophysiology of obesity and type 2 diabetes.

Our readers would enjoy learning about your favourite activities, hobbies, and interests outside of your professional work.

I enjoy spending time and traveling with family. I am fond of outdoor activities such as running, swimming, biking, and hiking.

Your reputation for innovation in obesity surgery is world renowned. Can you tell us briefly about the latest concepts in surgery education and  training you are involved in?

I use modern technological advances to conduct telemedicine-based conferences. Thanks to the internet, physicians and scientists around the world can share ideas from their home or office.

Opportunities to develop new procedures and medications to treat obesity have never been greater. I am optimistic about the future and our ability to prevent and treat obesity as well as associated co- morbidities in the years to come. Obesity is a disease that has risen to a high level of importance, and countries around the world need to pay attention.

EASO Newsletter January 2016

News from our 2016 Congress, EOS2016

In 2016 the congresses of EASO (ECO2016) and the IFSO European Chapter (2016 IFSO-EC Annual Congress) will merge to create the inaugural European Obesity Summit (EOS2016). This exciting congress will take place in Gothenburg, Sweden from 1 to 4 June 2016.

Thanks to all colleagues who submitted symposia suggestions and abstracts. We received a record number of submissions and authors will be informed of the status of their abstract by mid-February. In the meantime, the main scientific programme is regularly updated on the congress website.

Gothenburg has a lot to offer outside the congress. After some intensive scientific discussion you might like to visit the vibrant city centre, take a boat trip or let your hair down at the fairground!


c43248df-8a65-4680-b2d6-d548e9edf8dbEOS2016 Speaker Spotlight: Ruth Loos, PhD

Ruth Loos, PhD will participate in a review session on ‘personalised treatment of obesities’, giving a lecture on epigenetics. She will also coordinate a teaching workshop on the topic.

Read more about Ruth.

Country Spotlight: Italy


For EASO one of the most memorable moments of 2015 occurred on 6 June, when the Milan Declaration was formally presented during the Milan Expo in Italy. Read more.

European Obesity Day 2016

European Obesity Day 2016

Save the Date for European Obesity Day, 21 May 2016

Action for a Healthier Europe

At the recent Obesity Stakeholder Roundtable, EASO reaffirmed support for European Obesity Day, (#EOD2016) which will be held this year on 21 May 2016. #EOD2016 represents an important opportunity to engage and influence diverse stakeholders across Europe. Read more.

Obesity Facts

obesity facts

We are pleased to announce that the latest issue of Obesity Facts, 2016 issue 1 is available online. View the issue on the OFA website.

Festive FoodPatient Council Spotlight: Healthy Eating with Solveig Sigurdardottir

Patient Council Steering Committee member Sólveig Sigurðardóttir was recently interviewed by the Icelandic National Broadcasting Service – Ríkisútvarpið. Read more.

EASO RoundtableEASO Obesity Stakeholder Roundtable

On 13th January 2016 EASO convened a Roundtable meeting in Brussels on obesity in Europe. More than 30 stakeholders took part in the discussions, including medical professionals, patients, representatives from the World Health Organisation (WHO), Members from the European Parliament (MEPs), and some of the leading European organisations involved in the many illnesses for which obesity is a gateway disease. Read the full report.

European Obesity Day

Save the date: 21 May 2016

At the recent Obesity Stakeholder Roundtable, EASO reaffirmed support for European Obesity Day, (#EOD2016) which will be held this year on 21 May 2016.  #EOD2016 represents an important opportunity to engage and influence diverse stakeholders across Europe. At the Roundtable, there was affirmation across sectors for a joint programme of activities and events which will support an awareness and advocacy programme in each country and around Europe. During the coming weeks, EASO will launch an EOD website, and hope that you will use the Twitter hashtag #EOD2016 when you refer to the day using social media communications.

For more information see:

Obesity Stakeholder Roundtable

On 13th January 2016 EASO convened a Roundtable meeting on obesity in Brussels.  More than 30 stakeholders took part in the discussion, including medical professionals, patients, representatives from the World Health Organisation (WHO), Members from the European Parliament (MEPs), and some of the leading European organisations involved in the many illnesses for which obesity is a gateway disease.

Read the full report